Novel crystal form of 2-aminopyridine derivative and preparation method thereof

A crystallization, D-type technology, used in organic chemical methods, medical preparations containing active ingredients, separation/purification of carboxylic acid compounds, etc., can solve problems such as low positive rate, and achieve simple preparation methods and good thermal stability. , the effect of good liquidity

Pending Publication Date: 2022-05-06
CHIA TAI TIANQING PHARMA GRP CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In general non-small cell lung cancer patients, the positive rate of EML4-ALK fusion gene is low, about 3% to 7%.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel crystal form of 2-aminopyridine derivative and preparation method thereof
  • Novel crystal form of 2-aminopyridine derivative and preparation method thereof
  • Novel crystal form of 2-aminopyridine derivative and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0104] The preparation of embodiment 1 formula Ia compound

[0105] Dissolve 0.01mol of the compound of formula I in 90mL of methanol, add 10mL of citric acid-methanol solution with a concentration of 1.1mol / L under reflux and stir, and react for 1 hour, the reaction solution precipitates a solid, and continues to reflux hours, filtered, and the separated solid stirred at reflux in ethanol hour, filtered, and the separated solid was dried with air blast at 85°C under normal pressure to obtain crystals of the compound of formula Ia. The X-ray powder diffraction pattern using CuKa radiation was shown as type A crystals of WO2017016514, such as Figure 11 Shown, the diffraction peak in its X-ray diffraction pattern has following characteristics:

[0106]

[0107]

[0108] 1 H-NMR (500MHz, DMSO-d 6 ): δ=7.83(s, 1H), 7.57(t, J=4.95Hz, 1H), 7.55(d, J=1.45Hz, 1H), 7.46(t, J=8.7Hz, 1H), 6.81(d ,J=1.2Hz,1H),6.38(s,1H),5.98(q,J=6.7Hz,1H),5.73(brs,2H),4.79(brs,1H),4.26(d,J=13...

Embodiment 2

[0109] The preparation of the H type crystal of embodiment 2 formula Ia compound

[0110] Weigh 250 mg of the compound of formula Ia obtained in Example 1 into a 50 mL one-necked flask, add 40 mL of acetonitrile-water mixed solvent (acetonitrile: water (v / v) = 0.25:1) to obtain a suspension, then stir at room temperature for 24 hours, filter , and the separated solid was air-dried at 50° C. for 2 hours to obtain type H crystals of the compound of formula Ia.

[0111] 1 H-NMR (500MHz, DMSO-d 6 ):δ=7.81(s,1H),7.58(dd,J=9.0,4.9Hz,1H),7.53(d,J=1.8Hz,1H),7.47(t,J=8.7Hz,1H),6.78 (d,J=1.9Hz,1H),6.37(s,1H),5.97(q,J=6.7Hz,1H),5.75(s,2H),4.78(d,J=6.3Hz,1H),4.30 –4.19(m,1H),3.69(s,3H),3.30(d,J=12.2Hz,1H),3.23(d,J=12.6Hz,1H),3.18–3.08(m,2H),2.95( td,J=12.4,3.8Hz,1H),2.58(d,J=15.1Hz,2H),2.51(d,J=15.1Hz,2H),1.77(d,J=6.6Hz,3H),1.20( d, J=6.9Hz, 3H).

Embodiment 3

[0112] The preparation of the H type crystal of embodiment 3 formula Ia compound

[0113] Weigh 250 mg of the compound of formula Ia obtained in Example 1 into a 50 mL one-necked flask, add 40 mL of acetonitrile-water mixed solvent (acetonitrile: water (v / v) = 9:1) to obtain a suspension, then stir at room temperature for 24 hours, filter , and the separated solid was air-dried at 50° C. for 2 hours to obtain type H crystals of the compound of formula Ia.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of medicinal chemistry, and relates to a novel crystal form of a 2-aminopyridine derivative and a preparation method thereof, in particular to a citrate crystal of 5-((R)-1-(2, 6-dichloro-3-fluorophenyl) ethyoxyl)-4 '-methoxy-6'-((S)-2-methylpiperazine-1-yl)-3, 3 '-bipyridine-6-amine and a preparation method thereof, and more particularly relates to a citrate crystal of 5-((R)-1-(2, 6-dichloro-3-fluorophenyl) ethyoxyl)-4'-methoxy-6 '-((S)-2-methylpiperazine-1-yl)-3, 3'-bipyridine-6-amine and a preparation method thereof. The present invention relates to H-type, NH-type and D-type crystals of a citrate of (2, 6-dichloro-3-fluorophenyl) ethyoxyl)-4 '-methoxy-6'-((S)-2-methylpiperazine-1-yl)-3, 3 '-bipyridine-6-amine, and to a method for preparing the same.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry, and relates to crystal forms and preparation methods of 2-aminopyridine derivatives, in particular to 5-((R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy) Citrate crystal of -4'-methoxy-6'-((S)-2-methylpiperazin-1-yl)-3,3'bipyridin-6-amine and preparation method thereof. Background technique [0002] Protein kinases (PKs) represent a large class of proteins that play an important role in the control of cellular functions and the regulation of various cellular lesions, and can be divided into two categories: protein tyrosine kinases (PTKs) and serine-threonine kinases ( STKs). Protein Tyrosine Kinases (PTKs) are a class of enzymes that catalyze the transfer of phosphate groups from ATP to tyrosine residues on protein substrates, which play a role in normal cell growth. Studies have found that the cell signal transduction pathways of tyrosine kinases also play an extremely important role in the format...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/14C07C59/265C07C51/43A61P35/00A61P35/04A61K31/496
CPCC07D401/14C07C59/265A61P35/00A61P35/04C07B2200/13
Inventor 朱善良刘飞刘彦龙赵锐胡中元李新路臧海山
Owner CHIA TAI TIANQING PHARMA GRP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products